LOGIN  |  REGISTER
C4 Therapeutics

Bloomios (OTCMKTS: BLMS) Stock Quote

Last Trade: US$0.0001
Volume: 0
5-Day Change: -90.00%
YTD Change: -96.67%
Market Cap: US$6K

Latest News From Bloomios

HealthStocksHub
SANTA BARBARA, Calif. , June 9, 2023 /PRNewswire/ -- Bloomios, Inc. (OTCQB: BLMS), a leading innovator in contract manufacturing of hemp-derived cannabinoid & mushroom edibles, cosmetic & topical sports products, nootropics and adjacent wellness supplements, has appointed Kevin Henry to the new position of national sales... Read More
Annualized Run Rate Hits $11.0 Million vs. $6.1 million in 2022, Driven by Increased Order Flow and Production Capacity Q2 2023 Outlook of Revenues to Exceed $3 million , up more than 137% SANTA BARBARA, Calif. , June 1, 2023 /PRNewswire/ -- Bloomios, Inc. (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, reported results for the... Read More
SANTA BARBARA, Calif. , March 27, 2023 /PRNewswire/ -- Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has appointed Upexi's former production division operations head, Joe Reid , as chief manufacturing officer of Bloomios' wholly owned subsidiary, Bloomios Private Label. Reid brings to Bloomios more... Read More
Viking Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB